You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dexrazoxane

Showing 1 - 25 of 61
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Little Rock (Dexrazoxane)

Recruiting
  • Healthy
  • Dexrazoxane
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Mar 15, 2022

Heart Defects, Congenital Trial in Austin (Dexrazoxane)

Recruiting
  • Heart Defects, Congenital
  • Dexrazoxane
  • Austin, Texas
    Dell Children's Medical Center of Central Texas
Aug 2, 2021

Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blasts 10 Percent or More of Bone Marrow

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2022

MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)

Recruiting
  • Myelodysplastic Syndromes, de Novo
  • +10 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 23, 2023

Acute Lymphoblastic Leukemia Trial in United States (Everolimus, Prednisone, Vincristine)

Completed
  • Acute Lymphoblastic Leukemia
  • San Francisco, California
  • +7 more
Aug 5, 2022

Acute Lymphoblastic Leukemia, Pediatric Trial in Canada, United States (Pegaspargase, Erwinia asparaginase, Cyclophosphamide)

Active, not recruiting
  • Acute Lymphoblastic Leukemia, Pediatric
  • Boston, Massachusetts
  • +8 more
Nov 10, 2022

Sarcoma Trial in New York (biological, drug, procedure, radiation)

Active, not recruiting
  • Sarcoma
  • filgrastim
  • +10 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Nov 5, 2021

Drug/Agent Toxicity by Tissue/Organ, Leukemia Trial in Canada, Puerto Rico, United States (asparaginase, cyclophosphamide,

Completed
Has Results
  • Drug/Agent Toxicity by Tissue/Organ
  • Leukemia
  • Boston, Massachusetts
  • +9 more
Nov 9, 2022

Associated With Cardiomyopathy and Heart Failure After Cancer

Recruiting
  • Hodgkin Lymphoma in Remission
  • +6 more
  • Assessment of Therapy Complications
  • +3 more
  • Birmingham, Alabama
  • +78 more
Jan 11, 2023

Ewing's Sarcoma Trial in Houston (Vincristine, Doxorubicin, Cyclophosphamide)

Terminated
Has Results
  • Ewing's Sarcoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 17, 2020

Advanced Soft Tissue Sarcoma Trial in Bad Saarow, Berlin, Dresden (Olaratumab, Dexrazoxane, Doxorubicin)

Terminated
  • Advanced Soft Tissue Sarcoma
  • Bad Saarow, Germany
  • +3 more
Jul 13, 2020

Ganglioneuroblastoma, High Risk Neuroblastoma Trial in Australia, New Zealand, United States (procedure, drug, biological,

Active, not recruiting
  • Ganglioneuroblastoma
  • High Risk Neuroblastoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +14 more
  • Los Angeles, California
  • +9 more
Sep 1, 2022

Metastatic Soft Tissue Sarcoma, Advanced Soft Tissue Sarcoma Trial in Aurora (doxorubicin with AGEN1884 and AGEN2034)

Recruiting
  • Metastatic Soft Tissue Sarcoma
  • Advanced Soft Tissue Sarcoma
  • doxorubicin with AGEN1884 and AGEN2034
  • Aurora, Colorado
    University of Colorado Hospital
Jan 4, 2023

Cardiovascular Disease in Hodgkin Lymphoma Survivors

Not yet recruiting
  • Hodgkin Lymphoma
  • +3 more
  • Patient Self Reporting
  • +2 more
  • (no location specified)
Jan 20, 2023

Hepatoblastoma Trial in Shanghai (Sodium Thiosulfate Injection, Primary surgery resection, mono CDDP-Group A2)

Recruiting
  • Hepatoblastoma
  • Sodium Thiosulfate Injection
  • +10 more
  • Shanghai, Shanghai, China
    Shanghai Children's Medical Center
Jul 23, 2022

Acute Myeloid Leukemia Trial in Canada, Puerto Rico, United States (procedure, drug, behavioral)

Recruiting
  • Acute Myeloid Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +13 more
  • Birmingham, Alabama
  • +187 more
Apr 28, 2022

Acute Myeloid Leukemia in Children Trial (Standard Intervention, Investigational Intervention)

Not yet recruiting
  • Acute Myeloid Leukemia in Children
  • Standard Intervention
  • Investigational Intervention
  • (no location specified)
Aug 8, 2023

Cardiotoxicity Trial in Warsaw (Empagliflozin 10 MG, Placebo)

Not yet recruiting
  • Cardiotoxicity
  • Empagliflozin 10 MG
  • Placebo
  • Warsaw, Poland
  • +1 more
Mar 5, 2022

Ganglioneuroblastoma, Neuroblastoma Trial in Canada, Puerto Rico, United States (procedure, drug, biological, radiation)

Recruiting
  • Ganglioneuroblastoma
  • Neuroblastoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +18 more
  • Birmingham, Alabama
  • +158 more
Sep 14, 2022

Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in Toulouse (Doxorubicin, Cyclophosphamide)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • Metastatic Soft-tissue Sarcoma
  • Toulouse, France
    Institut Claudius Reagaud-IUCT Oncopôle
Oct 6, 2022

Sarcoma, Soft Tissue Trial in Berlin, Munich (DPPG2-TSL-DOX)

Recruiting
  • Sarcoma, Soft Tissue
  • Berlin, Germany
  • +1 more
May 12, 2023

Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial in Worldwide (procedure,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +21 more
  • Birmingham, Alabama
  • +219 more
Sep 15, 2022

Localized Extraskeletal Ewing Sarcoma, Peripheral Primitive Neuroectodermal Tumor of Bone, Peripheral Primitive Neuroectodermal

Active, not recruiting
Has Results
  • Localized Extraskeletal Ewing Sarcoma
  • +2 more
  • Birmingham, Alabama
  • +242 more
May 19, 2022

PRETEXT Stage 1 Hepatoblastoma, PRETEXT Stage 2 Hepatoblastoma, PRETEXT Stage 3 Hepatoblastoma Trial in Worldwide (drug, other,

Active, not recruiting
Has Results
  • PRETEXT Stage 1 Hepatoblastoma
  • +3 more
  • Birmingham, Alabama
  • +208 more
Jan 25, 2023

Relapsed Acute Lymphoblastic Leukemia, Allergy to PEG e.Coli Asparaginase, Allergy to Native e.Coli Asparaginase Trial in Los

Terminated
Has Results
  • Relapsed Acute Lymphoblastic Leukemia
  • +2 more
  • Los Angeles, California
    Childrens Hospital Los Angeles
Oct 2, 2018